Nodal metastasis risk in endometrioid endometrial cancer
- PMID: 22270280
- PMCID: PMC3266531
- DOI: 10.1097/AOG.0b013e318240de51
Nodal metastasis risk in endometrioid endometrial cancer
Abstract
Objective: To estimate the risk for nodal metastasis in women with endometrial cancer based on uterine characteristics on pathology.
Methods: From a study of staging for uterine cancer, women were identified as being at low risk for nodal metastasis based on three specific criteria on final pathology reports: 1) less than 50% invasion, 2) tumor size less than 2 cm, and 3) well or moderately differentiated endometrioid histology. If the uterine specimen did not meet all three criteria, it was viewed as high risk for nodal metastasis.
Results: Nine hundred seventy-one women were included in this analysis. Approximately 40% (or 389 of 971) of patients in this study were found to be at low risk, with a rate of nodal metastasis of only 0.8% (3 of 389; exact 95% confidence interval [CI] 0.16-2.2). No statistical differences in median age, body mass index, race, performance status, missing clinical data, or open or minimally invasive techniques were found among the patients with and without nodal metastases. Patients with high-risk characteristics of their uterine specimens compared with those with low-risk characteristics have 6.3 times the risk of nodal metastasis (95% CI 1.67-23.8, P=.007).
Conclusion: Low-risk endometrioid uterine cancer criteria may be used to help guide treatment planning for reoperation in patients with incomplete surgical staging information.
Level of evidence: II.
Conflict of interest statement
Figures
Similar articles
-
Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:63-7. doi: 10.1016/j.ejogrb.2015.01.006. Epub 2015 Jan 23. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 25638600
-
Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.Gynecol Oncol. 2014 May;133(2):216-20. doi: 10.1016/j.ygyno.2014.02.011. Epub 2014 Feb 16. Gynecol Oncol. 2014. PMID: 24548726
-
Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.Aust N Z J Obstet Gynaecol. 2015 Feb;55(1):81-6. doi: 10.1111/ajo.12321. Aust N Z J Obstet Gynaecol. 2015. PMID: 25688821
-
Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer.Gynecol Oncol. 2025 Mar;194:51-59. doi: 10.1016/j.ygyno.2025.02.012. Epub 2025 Feb 17. Gynecol Oncol. 2025. PMID: 39965448
-
Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.Gynecol Oncol. 2016 Mar;140(3):394-9. doi: 10.1016/j.ygyno.2015.12.028. Epub 2015 Dec 31. Gynecol Oncol. 2016. PMID: 26747778 Free PMC article.
Cited by
-
A Lymph Node Count-Based AJCC Staging System Facilitates a More Accurate Prediction of the Prognosis of Patients With Endometrial Cancer.Front Oncol. 2021 Mar 3;11:641962. doi: 10.3389/fonc.2021.641962. eCollection 2021. Front Oncol. 2021. PMID: 33747965 Free PMC article.
-
Endometrial cancer.Obstet Gynecol Clin North Am. 2012 Jun;39(2):255-68. doi: 10.1016/j.ogc.2012.04.001. Obstet Gynecol Clin North Am. 2012. PMID: 22640714 Free PMC article.
-
The impact of lymphadenectomy on cancerspecific survival in patients with low-grade endometrioid carcinoma of stage T1a.Sci Rep. 2025 May 7;15(1):15952. doi: 10.1038/s41598-025-00531-3. Sci Rep. 2025. PMID: 40335549 Free PMC article.
-
The effect of visceral obesity on clinicopathological features in patients with endometrial cancer: a retrospective analysis of 200 Chinese patients.BMC Cancer. 2016 Mar 11;16:209. doi: 10.1186/s12885-016-2230-4. BMC Cancer. 2016. PMID: 26968382 Free PMC article.
-
Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.BMC Cancer. 2024 Mar 25;24(1):380. doi: 10.1186/s12885-024-12127-7. BMC Cancer. 2024. PMID: 38528468 Free PMC article.
References
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. - PubMed
-
- Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–2041. - PubMed
-
- Schink JC, Lurain JR, Wallemark CB, Chmiel JS. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol. 1987;70:216–219. - PubMed
-
- Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–1519. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials